Effect of Immunosuppression in IgA Nephropathy
NCT03468972
·
clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
174
Enrollment
OTHER
Sponsor class
Conditions
Biopsy-proven IgA Nephropathy
Interventions
DRUG:
Immunosuppressive treatment
OTHER:
intensive supportive care
Sponsor
Yonsei University